Log in to your Inderes Free account to see all free content on this page.
Newbury Pharmaceuticals
3.52
SEK
+1.15 %
NEWBRY
First North Stockholm
Medical Equipment & Services
Health Care
2 following
+1.15%
-3.3%
+16.56%
+1.73%
+14.66%
-6.38%
-
-
-72.06%
Newbury Pharmaceuticals is a pharmaceutical company. The company develops a pipeline of in-house developed and licensed products with a focus on specialty drugs in areas such as oncology, rare diseases, and neurology. The company conducts its business within the Scandinavian market. Newbury Pharmaceuticals was founded in 2020 and has its headquarters in Lund.
Read moreMarket cap
85.39M SEK
Turnover
18.2K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
15.1.
2025
General meeting '24
24.1.
2025
Interim report Q1'25
9.4.
2025
Interim report Q2'25
ShowingAll content types
Kallelse till årsstämma i Newbury Pharmaceuticals AB
Newbury Pharmaceuticals Secures Generic Approval for Buspiron
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio